Lizotte et al. developed an in vitro luciferase-based screening assay to identify small molecules, which modulate T-cell-mediated killing of tumor cells and validated epidermal growth factor receptor (EGFR) inhibitors at potentiators of anti-PD-1 immunotherapy [193]. The gene discussed is PDCD1; the disease is neoplasm.